Here's the live share price of SMS Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of SMS Pharmaceuticals has gained 28.48% CAGR. Over the past year, the corresponding return has been -3.16%.
SMS Pharmaceuticals’s current P/E of 34.58x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| SMS Pharmaceuticals | -4.37 | 10.32 | 21.79 | 19.10 | -3.16 | 47.23 | 28.48 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, SMS Pharmaceuticals has declined 3.16% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, SMS Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 293.6 | 291.6 |
| 10 | 289.39 | 289.49 |
| 20 | 276.66 | 283.57 |
| 50 | 264.55 | 270.34 |
| 100 | 252.18 | 258.95 |
| 200 | 236.64 | 249.76 |
In the latest quarter, SMS Pharmaceuticals remained same as its previous close in promoter holding, while DII stake unchanged at 2.88%, FII holding rose to 0.28%, and public shareholding moved down to 28.77% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 18,59,681 | 0.16 | 45.68 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 16, 2025, 5:58 AM IST | SMS Pharmaceuticals - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regu |
| Oct 10, 2025, 11:40 PM IST | SMS Pharmaceuticals - Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window |
| Oct 10, 2025, 10:34 PM IST | SMS Pharmaceuticals - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 30, 2025, 12:55 AM IST | SMS Pharmaceuticals - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
| Sep 29, 2025, 9:09 PM IST | SMS Pharmaceuticals - Shareholder Meeting / Postal Ballot-Outcome of AGM |
SMS Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 782.75 Cr. and Equity Capital is Rs. 8.87 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for SMS Pharmaceuticals is ₹285.30 as on Oct 31, 2025.
The SMS Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of SMS Pharmaceuticals is ₹2,529.24 Cr as on Oct 31, 2025.
Today’s highest and lowest price of SMS Pharmaceuticals are ₹290.05 and ₹284.15.
The 52-week high/low is the highest and lowest price at which SMS Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of SMS Pharmaceuticals is ₹318.80 and 52-week low of SMS Pharmaceuticals is ₹175.00 as on Oct 31, 2025.
The SMS Pharmaceuticals has shown returns of -1.14% over the past day, 10.32% for the past month, 21.79% over 3 months, -3.16% over 1 year, 47.23% across 3 years, and 28.48% over 5 years.
P/E ratio of and PB ratio of SMS Pharmaceuticals are 34.58 and 4.48 on Oct 31, 2025. While the company gives a dividend yield of 0.14 per annum.